• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Cardiovascular
  • Dyslipaemia, atherosclerosis risk and increased hsCRP and inflammatory and oxidative status in the Spanish population

Disease
dyslipidaemia
Drug Name
non drug study (cardiovascular)
Generic Name
No Drug
Sponsor
AstraZeneca
Drug Status
In Development
Phase
Non-Interventional Study
Start Date
Nov 23, 2009
Study Name
NIS-CES-DUM-2009/1
Study Id
NIS-CES-DUM-2009/1
ClinicalTrials.gov ID
NCT00998062
Recruiting Status
Closed
Protocol Status
Not Available
Report
Jun 14, 2012
  • NIS-CES-DUM-2009/1 (553 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013